GlassScriptPhysician profile
Shuaib Malik
NPI 1841469806
$63,680.03
in general payments reported to CMS, 2019-2025
10 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2021: $5,320 · 2022: $245 · 2023: $470 · 2024: $19K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $15K · Food and Beverage: $1,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,996.37 |
| Travel and Lodging | $14,508.23 |
| Food and Beverage | $1,983.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $22,301.81 | 2019-2023 | Nobelactive |
| Envista Holdings Corporation | $17,892.70 | 2024 | Education |
| Restor3d, INC. | $16,732.35 | 2025 | |
| Biohorizons Implant Systems INC. | $6,556.16 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Henry Schein, INC. | $52.43 | 2019 | |
| Keystone Dental INC. | $45.77 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $37.02 | 2024-2025 | Exparel |
| Straumann USA LLC | $25.00 | 2022 | |
| Carestream Dental, LLC | $18.68 | 2021 | |
| Biolase, INC. | $18.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$364,783.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shuaib Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.